Back to Journals » Therapeutics and Clinical Risk Management » Volume 9 » default

Therapeutics and Clinical Risk Management


Archive: Volume 9, 2013

Colchicine intoxication: a report of two suicide cases

Erden A, Karagoz H, Gümüscü HH, Karahan S, Basak M, Aykas F, Bulut K, Cetinkaya A, Avci D, Poyrazoglu OK

Therapeutics and Clinical Risk Management 2013, 9:505-509

Published Date: 5 December 2013

National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool

Ramli A, Aljunid SM, Sulong S, Md Yusof FA

Therapeutics and Clinical Risk Management 2013, 9:491-504

Published Date: 4 December 2013

Pseudobulbar affect: prevalence and management

Ahmed A, Simmons Z

Therapeutics and Clinical Risk Management 2013, 9:483-489

Published Date: 29 November 2013

Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study

Rossi L, Tomao F, Lo Russo G, Papa A, Zoratto F, Marzano R, Basso E, Giordani E, Verrico M, Ricci F, Pasciuti G, Francini E, Tomao S

Therapeutics and Clinical Risk Management 2013, 9:457-462

Published Date: 11 November 2013

Treatment approaches and antibiotic use for emergency dental treatment in Turkey

Kaptan RF, Haznedaroglu F, Basturk FB, Kayahan MB

Therapeutics and Clinical Risk Management 2013, 9:443-449

Published Date: 7 November 2013

Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients

Stonecipher KG, Chia J, Onyenwenyi A, Villanueva L, Hollander DA

Therapeutics and Clinical Risk Management 2013, 9:409-415

Published Date: 25 October 2013

Eliminating the need for fasting with oral administration of bisphosphonates

Pazianas M, Abrahamsen B, Ferrari S, Russell RGG

Therapeutics and Clinical Risk Management 2013, 9:395-402

Published Date: 18 October 2013

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization

Petrou P, Georgalas I, Markomichelakis N, Vergados I, Gianakaki E, Rouvas A

Therapeutics and Clinical Risk Management 2013, 9:391-394

Published Date: 18 October 2013

Obesity detection rate among primary school students in the People's Republic of China: a meta-analysis

Jin Y, Ding L, Yao Y, Song X, Tang H, He L, Chen Y

Therapeutics and Clinical Risk Management 2013, 9:383-390

Published Date: 11 October 2013

A 6-year experience of CPR outcomes in an emergency department in Thailand

Sittichanbuncha Y, Prachanukool T, Sawanyawisuth K

Therapeutics and Clinical Risk Management 2013, 9:377-381

Published Date: 8 October 2013

The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients

Dang Y, Mu Y, Zhao M, Li L, Guo Y, Zhu Y

Therapeutics and Clinical Risk Management 2013, 9:355-360

Published Date: 2 September 2013

Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers

Del Tacca M, Pasqualetti G, Gori G, Pepe P, Di Paolo A, Lastella M, De Negri F, Blandizzi C

Therapeutics and Clinical Risk Management 2013, 9:303-311

Published Date: 24 July 2013

Evaluation of recombinant activated protein C for severe sepsis at a tertiary academic medical center

Anger KE, DeGrado JR, Greenwood BC, Cohen SA, Szumita PM

Therapeutics and Clinical Risk Management 2013, 9:277-284

Published Date: 5 June 2013

Case of femoral diaphyseal stress fracture after long-term risedronate administration diagnosed by iliac bone biopsy

Nagai T, Sakamoto K, Ishikawa K, Saito E, Kuroda T, Inagaki K

Therapeutics and Clinical Risk Management 2013, 9:191-195

Published Date: 30 April 2013

Vitamin D reduces falls and hip fractures in vascular Parkinsonism but not in Parkinson’s disease

Sato Y, Iwamoto J, Honda Y, Amano N

Therapeutics and Clinical Risk Management 2013, 9:171-176

Published Date: 22 April 2013

Tolerability of diclofenac sodium 1% gel with concomitant medications known to interact with diclofenac

Peniston JH, Gold MS, Wieman MS, Alwine LK

Therapeutics and Clinical Risk Management 2013, 9:153-159

Published Date: 16 April 2013

Clinical development of neridronate: potential for new applications

Gatti D, Rossini M, Viapiana O, Idolazzi L, Adami S

Therapeutics and Clinical Risk Management 2013, 9:139-147

Published Date: 3 April 2013

Gender, airborne chemical monitoring, and physical work environment are related to indoor air symptoms among nonindustrial workers in the Klang Valley, Malaysia

Syazwan AI, Hafizan J, Baharudin MR, Azman AZF, Izwyn Z, Zulfadhli I, Syahidatussyakirah K

Therapeutics and Clinical Risk Management 2013, 9:87-105

Published Date: 8 March 2013

Diagnosis and management of miliary tuberculosis: current state and future perspectives

Ray S, Talukdar A, Kundu S, Khanra D, Sonthalia N

Therapeutics and Clinical Risk Management 2013, 9:9-26

Published Date: 8 January 2013